These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 21707397

  • 21. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
    Burendahl S, Danciulescu C, Nilsson L.
    Proteins; 2009 Dec; 77(4):842-56. PubMed ID: 19626711
    [Abstract] [Full Text] [Related]

  • 22. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
    Peng T, Pei J, Zhou J.
    J Chem Inf Comput Sci; 2003 Dec; 43(1):298-303. PubMed ID: 12546565
    [Abstract] [Full Text] [Related]

  • 23. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
    McDevitt RE, Malamas MS, Manas ES, Unwalla RJ, Xu ZB, Miller CP, Harris HA.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3137-42. PubMed ID: 15876535
    [Abstract] [Full Text] [Related]

  • 24. Ligand-based assessment of factor Xa binding site flexibility via elaborate pharmacophore exploration and genetic algorithm-based QSAR modeling.
    Taha MO, Qandil AM, Zaki DD, AlDamen MA.
    Eur J Med Chem; 2005 Jul 15; 40(7):701-27. PubMed ID: 15935905
    [Abstract] [Full Text] [Related]

  • 25. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
    Shen J, Li W, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2009 Jul 30; 113(30):10436-44. PubMed ID: 19583238
    [Abstract] [Full Text] [Related]

  • 26. 5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling.
    Oberdorf C, Schmidt TJ, Wünsch B.
    Eur J Med Chem; 2010 Jul 30; 45(7):3116-24. PubMed ID: 20427100
    [Abstract] [Full Text] [Related]

  • 27. Indazole estrogens: highly selective ligands for the estrogen receptor beta.
    De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 2005 Feb 24; 48(4):1132-44. PubMed ID: 15715479
    [Abstract] [Full Text] [Related]

  • 28. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors.
    Weber A, Böhm M, Supuran CT, Scozzafava A, Sotriffer CA, Klebe G.
    J Chem Inf Model; 2006 Feb 24; 46(6):2737-60. PubMed ID: 17125213
    [Abstract] [Full Text] [Related]

  • 29. 3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptor.
    Geldenhuys WJ, Simmons MA.
    Bioorg Med Chem Lett; 2011 Dec 15; 21(24):7405-11. PubMed ID: 22056747
    [Abstract] [Full Text] [Related]

  • 30. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design.
    Ye Y, Liao Q, Wei J, Gao Q.
    Neurochem Int; 2010 Jan 15; 56(1):107-17. PubMed ID: 19782115
    [Abstract] [Full Text] [Related]

  • 31. Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.
    Mor M, Rivara S, Lodola A, Lorenzi S, Bordi F, Plazzi PV, Spadoni G, Bedini A, Duranti A, Tontini A, Tarzia G.
    Chem Biodivers; 2005 Nov 15; 2(11):1438-51. PubMed ID: 17191945
    [Abstract] [Full Text] [Related]

  • 32. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 1999 Jul 01; 42(13):2456-68. PubMed ID: 10395487
    [Abstract] [Full Text] [Related]

  • 33. Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.
    Weber KC, Salum LB, Honório KM, Andricopulo AD, da Silva AB.
    Eur J Med Chem; 2010 Apr 01; 45(4):1508-14. PubMed ID: 20133028
    [Abstract] [Full Text] [Related]

  • 34. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K, Lindner M, Pianwanit S, Kokpol S, Sippl W.
    Eur J Med Chem; 2009 Apr 01; 44(4):1383-95. PubMed ID: 18976834
    [Abstract] [Full Text] [Related]

  • 35. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Pan D, Tseng Y, Hopfinger AJ.
    J Chem Inf Comput Sci; 2003 Apr 01; 43(5):1591-607. PubMed ID: 14502494
    [Abstract] [Full Text] [Related]

  • 36. Computational modeling of biologically active molecules using NMR spectra.
    Beger RD.
    Drug Discov Today; 2006 May 01; 11(9-10):429-35. PubMed ID: 16635805
    [Abstract] [Full Text] [Related]

  • 37. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD, Hamza A, Liu J, Zhan CG.
    J Chem Inf Model; 2008 Sep 01; 48(9):1760-72. PubMed ID: 18717540
    [Abstract] [Full Text] [Related]

  • 38. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V.
    J Med Chem; 2006 Oct 19; 49(21):6155-7. PubMed ID: 17034120
    [Abstract] [Full Text] [Related]

  • 39. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI, Norman BH, Lugar CW, Jones SA, Wang Y, Durbin JD, Krishnan V, Dodge JA.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3570-4. PubMed ID: 17485205
    [Abstract] [Full Text] [Related]

  • 40. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y, Liu H, Niu C, Luo C, Luo X, Shen J, Chen K, Jiang H.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6193-208. PubMed ID: 15519163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.